Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Karla Molinero & Jesse D. Hinckley. (2023) Adolescent Cannabis Use, Comorbid Attention-Deficit/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders. Psychiatric Clinics of North America 46:4, pages 691-702.
Crossref
Crossref
Marjorie Camus Charron & Nathalie Duriez. (2023) Exploration des interactions entre le TDAH, la régulation émotionnelle et les conduites addictives. Étude de deux jeunes adultes. Psychotropes Vol. 29:2, pages 169-194.
Crossref
Crossref
Alison Looby, Mark A. Prince, Nicholas R. Livingston & Katherine A. Berry. (2023) An examination of the effects of ADHD symptoms and sex on the relation between cannabis protective behavioral strategies and cannabis consequences. Addictive Behaviors 144, pages 107718.
Crossref
Crossref
Margherita Barbuti, Marco Maiello, Vincenza Spera, Alessandro Pallucchini, Giulio E. Brancati, Angelo G. I. Maremmani, Giulio Perugi & Icro Maremmani. (2023) Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician. Journal of Clinical Medicine 12:9, pages 3096.
Crossref
Crossref
Karla Molinero & Jesse D. Hinckley. (2023) Adolescent Cannabis Use, Comorbid Attention-Deficit/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders. Child and Adolescent Psychiatric Clinics of North America 32:1, pages 57-68.
Crossref
Crossref
Zhao-Min Wu, Peng Wang, Lu Liu, Juan Liu, Xiao-Lan Cao, Li Sun, Qing-Jiu Cao, Li Yang, Yu-Feng Wang & Bin-Rang Yang. (2022) ADHD-inattentive versus ADHD-Combined subtypes: A severity continuum or two distinct entities? A comprehensive analysis of clinical, cognitive and neuroimaging data. Journal of Psychiatric Research 149, pages 28-36.
Crossref
Crossref
Corné Coetzee, Ilse Truter & Anneke Meyer. (2022) Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder. South African Journal of Psychiatry 28.
Crossref
Crossref
Dorothy Wallis, J. Douglas Coatsworth, Jeremy Mennis, Nathaniel R. Riggs, Nikola Zaharakis, Michael A. Russell, Aaron R. Brown, Stephanie Rayburn, Aubrie Radford, Christopher Hale & Michael J. Mason. (2022) Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use. International Journal of Environmental Research and Public Health 19:3, pages 1850.
Crossref
Crossref
François Arnaud Matthieu Jean, Julie Arsandaux, Ilaria Montagni, Ophélie Collet, Mélina Fatséas, Marc Auriacombe, Josep Antoni Ramos-Quiroga, Sylvana M. Côté, Christophe Tzourio & Cédric Galéra. (2022) Attention deficit hyperactivity disorder symptoms and cannabis use after 1 year among students of the i-Share cohort. European Psychiatry 65:1.
Crossref
Crossref
Alexandra P. Lam, Sebastian Moeller, Christine Speitling, Martin C. Lam, Alexandra Philipsen & Helge H. O. Müller. (2020) Consumption of Synthetic Cannabinoids in Adult Attention-Deficit/Hyperactivity Disorder: a Pilot Study. International Journal of Mental Health and Addiction 19:5, pages 1586-1604.
Crossref
Crossref
Melissa Parlar, Emily MacKillop, Tashia Petker, James Murphy & James MacKillop. (2021) Cannabis Use, Age of Initiation, and Neurocognitive Performance: Findings from a Large Sample of Heavy Drinking Emerging Adults. Journal of the International Neuropsychological Society 27:6, pages 533-545.
Crossref
Crossref
Tashia Petker, Mark Ferro, Michael Van Ameringen, James Murphy & James MacKillop. (2021) Daily, but not occasional, cannabis use is selectively associated with more impulsive delay discounting and hyperactive ADHD symptoms in binge-drinking young adults. Psychopharmacology 238:7, pages 1753-1763.
Crossref
Crossref
Vincenza Spera, Alessandro Pallucchini, Marco Carli, Marco Maiello, Angelo Maremmani, Giulio Perugi & Icro Maremmani. (2021) Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture?. Journal of Clinical Medicine 10:7, pages 1481.
Crossref
Crossref
María Soler Artigas, Cristina Sánchez-Mora, Paula Rovira, Vanesa Richarte, Iris Garcia-Martínez, Mireia Pagerols, Ditte Demontis, Sven Stringer, Jacqueline M. Vink, Anders D. Børglum, Benjamin M. Neale, Barbara Franke, Stephen V. Faraone, Miguel Casas, Josep Antoni Ramos-Quiroga & Marta Ribasés. (2019) Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. Molecular Psychiatry 25:10, pages 2493-2503.
Crossref
Crossref
Morgan M Philbin, Pia M Mauro, Emily R Greene, Natalie J LaBossier, Daniel P Giovenco & Silvia S Martins. (2020) Medical cannabis laws and medical and non-medical prescription stimulant use among a nationally representative sample of US Adults: Examining the role of sexual identity and gender. International Journal of Drug Policy 84, pages 102861.
Crossref
Crossref
Daniel P. Notzon, Martina Pavlicova, Andrew Glass, John J. Mariani, Amy L. Mahony, Daniel J. Brooks & Frances R. Levin. (2016) ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders. Journal of Attention Disorders 24:11, pages 1487-1492.
Crossref
Crossref
Andrea J. Capusan, Preben Bendtsen, Ina Marteinsdottir & Henrik Larsson. (2016) Comorbidity of Adult ADHD and Its Subtypes With Substance Use Disorder in a Large Population-Based Epidemiological Study. Journal of Attention Disorders 23:12, pages 1416-1426.
Crossref
Crossref
Natalia Estévez-Lamorte, Simon Foster, Dominique Eich-Höchli, Franz Moggi, Gerhard Gmel & Meichun Mohler-Kuo. (2018) Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: a follow-up study among young men. European Archives of Psychiatry and Clinical Neuroscience 269:6, pages 667-679.
Crossref
Crossref
Aleksi Mikael Markunpoika Hupli. (2018) Medical Cannabis for Adult Attention Deficit Hyperactivity Disorder: Sociological Patient Case Report of Cannabinoid Therapeutics in Finland. Medical Cannabis and Cannabinoids 1:2, pages 112-118.
Crossref
Crossref
Ariel Brandt, Jürgen Rehm & Shaul Lev-Ran. (2018) Clinical Correlates of Cannabis Use Among Individuals With Attention Deficit Hyperactivity Disorder. Journal of Nervous & Mental Disease 206:9, pages 726-732.
Crossref
Crossref
Ruth E. Cooper, Emma Williams, Seth Seegobin, Charlotte Tye, Jonna Kuntsi & Philip Asherson. (2017) Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. European Neuropsychopharmacology 27:8, pages 795-808.
Crossref
Crossref
Kristine Fiksdal Abel, Edle Ravndal, Thomas Clausen & Jørgen G. Bramness. (2017) Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment. European Addiction Research 23:6, pages 298-305.
Crossref
Crossref
K.E. Maple, N.E. Wright & K.M. Lisdahl. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
e64
e71
.
Abbas Khani & Gregor Rainer. (2016) Neural and neurochemical basis of reinforcement-guided decision making. Journal of Neurophysiology 116:2, pages 724-741.
Crossref
Crossref
Abbas Khani, Mojtaba Kermani, Soghra Hesam, Abbas Haghparast, Enrike G. Argandoña & Gregor Rainer. (2014) Activation of cannabinoid system in anterior cingulate cortex and orbitofrontal cortex modulates cost-benefit decision making. Psychopharmacology 232:12, pages 2097-2112.
Crossref
Crossref
Donald E. Greydanus, Gabriel Kaplan, Louis E. BaxterSrSr, Dilip R. Patel & Cynthia L. Feucht. (2015) Cannabis: The never-ending, nefarious nepenthe of the 21st century: What should the clinician know?. Disease-a-Month 61:4, pages 118-175.
Crossref
Crossref